Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Laura Soucek
BET Inhibition Is an Effective Approach Against KRAS-driven PDAC and NSCLC
Oncotarget
Oncology
Reversible Kinetic Analysis of Myc TargetsIn vivoProvides Novel Insights Into Myc-Mediated Tumorigenesis
Cancer Research
Cancer Research
Oncology
Related publications
Targeted Inhibition of Superoxide Dismutase 1 Is Effective in NSCLC
Cancer Discovery
Oncology
KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination With PI3K Inhibition.
Clinical Cancer Research
Cancer Research
Oncology
KRAS Mutation as a Resistance Mechanism to BRAF/MEK Inhibition in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PD-L1 Is a Direct Target of Cancer-Foxp3 in Pancreatic Ductal Adenocarcinoma (PDAC), and Combined Immunotherapy With Antibodies Against PD-L1 and CCL5 Is Effective in the Treatment of PDAC
Signal Transduction and Targeted Therapy
Cancer Research
Genetics
mTORC1 Inhibition Is an Effective Treatment for Sporadic Renal Angiomyolipoma
Kidney International Reports
Nephrology
Hes1 Plays an Essential Role in Kras-Driven Pancreatic Tumorigenesis
Oncogene
Cancer Research
Genetics
Molecular Biology
Erratum: Mechanism of MEK Inhibition Determines Efficacy in Mutant KRAS- Versus BRAF-driven Cancers
Nature
Multidisciplinary
BET Proteins: An Approach to Future Therapies in Transplantation
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Simultaneous Bet/Crebbp/Ep300 Targeting Approach Compared to Single Bet or Crebbp/Ep300 Inhibition in Diffuse Large B-Cell Lymphoma (Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
